Bank of America’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.68M | Sell |
325,352
-119,351
| -27% | -$2.08M | ﹤0.01% | 3206 |
|
|
2025
Q1 | $5.59M | Buy |
444,703
+283,745
| +176% | +$3.57M | ﹤0.01% | 3122 |
|
|
2024
Q4 | $1.7M | Buy |
160,958
+48,094
| +43% | +$507K | ﹤0.01% | 3878 |
|
|
2024
Q3 | $1.64M | Buy |
112,864
+4,790
| +4% | +$69.5K | ﹤0.01% | 3979 |
|
|
2024
Q2 | $920K | Buy |
108,074
+26,495
| +32% | +$225K | ﹤0.01% | 4222 |
|
|
2024
Q1 | $834K | Sell |
81,579
-17,019
| -17% | -$174K | ﹤0.01% | 4270 |
|
|
2023
Q4 | $540K | Buy |
98,598
+42,154
| +75% | +$231K | ﹤0.01% | 4567 |
|
|
2023
Q3 | $213K | Buy |
56,444
+30,018
| +114% | +$113K | ﹤0.01% | 5012 |
|
|
2023
Q2 | $177K | Buy |
26,426
+1,926
| +8% | +$12.9K | ﹤0.01% | 5087 |
|
|
2023
Q1 | $159K | Buy |
24,500
+11,261
| +85% | +$73.3K | ﹤0.01% | 5253 |
|
|
2022
Q4 | $113K | Buy |
13,239
+2,785
| +27% | +$23.8K | ﹤0.01% | 5431 |
|
|
2022
Q3 | $55K | Sell |
10,454
-232,987
| -96% | -$1.23M | ﹤0.01% | 5792 |
|
|
2022
Q2 | $1.03M | Sell |
243,441
-20,425
| -8% | -$86.7K | ﹤0.01% | 4224 |
|
|
2022
Q1 | $926K | Buy |
263,866
+240,090
| +1,010% | +$843K | ﹤0.01% | 4681 |
|
|
2021
Q4 | $158K | Buy |
23,776
+20,490
| +624% | +$136K | ﹤0.01% | 5819 |
|
|
2021
Q3 | $32K | Sell |
3,286
-29,932
| -90% | -$291K | ﹤0.01% | 6340 |
|
|
2021
Q2 | $1.03M | Buy |
33,218
+6,459
| +24% | +$199K | ﹤0.01% | 4225 |
|
|
2021
Q1 | $1.17M | Buy |
+26,759
| New | +$1.17M | ﹤0.01% | 4141 |
|